Last reviewed · How we verify
Human Secretin
At a glance
| Generic name | Human Secretin |
|---|---|
| Also known as | ChiRhoStim |
| Sponsor | Mayo Clinic |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
- Nausea
- Vomiting
- Flushing
- Upset stomach
Key clinical trials
- Imaging Biomarkers of Pancreatic Function and Disease (PHASE4)
- Secretin in Refeeding
- A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects (PHASE4)
- Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
- The Cancer of the Pancreas Screening-5 CAPS5)Study (PHASE3)
- The Effects of Bariatric Surgeries on Glucose Metabolism (EARLY_PHASE1)
- The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
- The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |